Another group also showed positive effect of SGLT2 inhibitors on LV systolic and diastolic function [26], whereas, Roy et al. recently reported that SGLT-2 inhibitors did not appear to the improvement of LV diastolic functional parameters in HFpEF patients with T2DM [27]. Here, SLC5A2 is linked to type 2 diabetes mellitus.